Tristel (TSTL) - Total Liabilities

Latest as of December 2025: GBX11.88 Million GBX ≈ $1.45K USD

Based on the latest financial reports, Tristel (TSTL) has total liabilities worth GBX11.88 Million GBX (≈ $1.45K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Tristel cash flow conversion to assess how effectively this company generates cash.

Tristel - Total Liabilities Trend (2003–2025)

This chart illustrates how Tristel's total liabilities have evolved over time, based on quarterly financial data. Check Tristel asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Tristel Competitors by Total Liabilities

The table below lists competitors of Tristel ranked by their total liabilities.

Company Country Total Liabilities
Orion Equities Ltd
AU:OEQ
Australia AU$254.12K
Neurizer Ltd
AU:NRZ
Australia AU$60.54 Million
Begbies Traynor Group PLC
LSE:BEG
UK GBX83.60 Million
Vast Renewables Limited Ordinary Shares
NASDAQ:VSTE
USA $24.07 Million
Himalaya Energi Perkasa Tbk PT
JK:HADE
Indonesia Rp1.28 Billion
Kestrel Gold Inc
V:KGC
Canada CA$35.81K
Providence Gold Mines
V:PHD
Canada CA$248.33K
Hansa Trust
LSE:HAN
UK GBX1.42 Million

Liability Composition Analysis (2003–2025)

This chart breaks down Tristel's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see TSTL market cap.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 4.13 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.35 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.26 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tristel's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tristel (2003–2025)

The table below shows the annual total liabilities of Tristel from 2003 to 2025.

Year Total Liabilities Change
2025-06-30 GBX12.34 Million
≈ $1.50K
+5.50%
2024-06-30 GBX11.70 Million
≈ $1.42K
+9.51%
2023-06-30 GBX10.68 Million
≈ $1.30K
+9.54%
2022-06-30 GBX9.75 Million
≈ $1.19K
-0.96%
2021-06-30 GBX9.85 Million
≈ $1.20K
-21.03%
2020-06-30 GBX12.47 Million
≈ $1.52K
+142.91%
2019-06-30 GBX5.13 Million
≈ $624.66
+24.82%
2018-06-30 GBX4.11 Million
≈ $500.43
+1.56%
2017-06-30 GBX4.05 Million
≈ $492.77
+5.91%
2016-06-30 GBX3.82 Million
≈ $465.27
+34.27%
2015-06-30 GBX2.85 Million
≈ $346.52
-5.22%
2014-06-30 GBX3.00 Million
≈ $365.62
+60.61%
2013-06-30 GBX1.87 Million
≈ $227.65
-19.70%
2012-06-30 GBX2.33 Million
≈ $283.49
+16.79%
2011-06-30 GBX2.00 Million
≈ $242.73
-42.19%
2010-06-30 GBX3.45 Million
≈ $419.89
+97.43%
2009-06-30 GBX1.75 Million
≈ $212.68
+21.39%
2008-06-30 GBX1.44 Million
≈ $175.21
-29.62%
2007-06-30 GBX2.05 Million
≈ $248.94
+46.14%
2006-06-30 GBX1.40 Million
≈ $170.34
+15.61%
2005-06-30 GBX1.21 Million
≈ $147.34
+18.03%
2004-04-30 GBX1.03 Million
≈ $124.83
0.00%
2003-06-30 GBX1.03 Million
≈ $124.83
--

About Tristel

LSE:TSTL UK Medical Instruments & Supplies
Market Cap
$2.36 Million
GBX19.41 Billion GBX
Market Cap Rank
#29498 Global
#643 in UK
Share Price
GBX405.00
Change (1 day)
+3.32%
52-Week Range
GBX345.00 - GBX440.00
All Time High
GBX617.87
About

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for … Read more